Deferred registration: Quotient Sciences code: QSC303996

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN54346737

Enrollment

Registered

2026-05-18

Start date

2026-05-15

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers Other

Interventions

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Eligibility

Sex/Gender

Male

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Exclusion criteria

Exclusion criteria: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Countries

England, United Kingdom

Contacts

Public ContactClinical Study Director

clinicaltrials@orionpharma.com+358 10 4261

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 11, 2026